Healthcare charts

Asia Pacific Irritable Bowel Syndrome Treatment Market By Type Forecast (2015-2023)

Ibs d segment accounted for the largest market share in 2017, this market is expected to reach usd 308.40 million in 2023 from usd 201.50 million in 2017. this market is projected to grow at a cagr of 6.89% during the forecast period from 2018 - 20

Asia Pacific Irritable Bowel Syndrome Treatment Market By Drug Type Forecast (2015-2023)

Linaclotide segment accounted for the largest market share in 2017, this market is expected to reach usd 165.10 million in 2023 from usd 110.00 million in 2017. this market is projected to grow at a cagr of 6.54% during the forecast period from 201

Asia Pacific Irritable Bowel Syndrome Treatment Market By End User Forecast (2015-2023)

Hospitals segment accounted for the largest market share in 2017, this market is expected to reach usd 216.20 million in 2023 from usd 143.20 million in 2017. this market is projected to grow at a cagr of 6.62% during the forecast period from 2018

Asia Pacific Irritable Bowel Syndrome Treatment Market Forecast (2015-2023)

Japan accounted for the largest market share in 2017 in the asia pacific irritable bowel syndrome treatment market, and is expected to reach usd 137.30 million in 2023 from usd 93.40 million in 2017. however, india is the fastest growing market, wh

Europe Irritable Bowel Syndrome Treatment Market By Type Forecast (2015-2023)

Ibs d segment accounted for the largest market share in 2017, this market is expected to reach usd 510.40 million in 2023 from usd 315.70 million in 2017. this market is projected to grow at a cagr of 8.04% during the forecast period from 2018 - 20

Europe Irritable Bowel Syndrome Treatment Market By Drug Type Forecast (2015-2023)

Linaclotide segment accounted for the largest market share in 2017, this market is expected to reach usd 273.20 million in 2023 from usd 172.30 million in 2017. this market is projected to grow at a cagr of 7.68% during the forecast period from 201

Europe Irritable Bowel Syndrome Treatment Market By End User Forecast (2015-2023)

Hospitals segment accounted for the largest market share in 2017, this market is expected to reach usd 357.80 million in 2023 from usd 224.40 million in 2017. this market is projected to grow at a cagr of 7.77% during the forecast period from 2018

Europe Irritable Bowel Syndrome Treatment Market Forecast (2015-2023)

Eastern-europe accounted for the largest market share in 2017 in the europe irritable bowel syndrome treatment market, and is expected to reach usd 231.53 million in 2023 from usd 150.84 million in 2017. however, united kingdom is the fastest growi

South America Irritable Bowel Syndrome Treatment Market By Type Forecast (2015-2023)

Ibs d segment accounted for the largest market share in 2017, this market is expected to reach usd 206.10 million in 2023 from usd 113.20 million in 2017. this market is projected to grow at a cagr of 10.75% during the forecast period from 2018 - 2

South America Irritable Bowel Syndrome Treatment Market By Drug Type Forecast (2015-2023)

Linaclotide segment accounted for the largest market share in 2017, this market is expected to reach usd 110.30 million in 2023 from usd 61.80 million in 2017. this market is projected to grow at a cagr of 10.39% during the forecast period from 201